Last reviewed · How we verify
SonoVue®
SonoVue is a microbubble ultrasound contrast agent that enhances ultrasound imaging.
SonoVue is a microbubble ultrasound contrast agent that enhances ultrasound imaging. Used for Enhanced ultrasound imaging of the liver, spleen, and other organs.
At a glance
| Generic name | SonoVue® |
|---|---|
| Also known as | sulfur hexafluoride microbubbles, SonoVue sulphur hexafluoride microbubbles 8 microlitres/ml, Powder and solvent for dispersion for injection., MARKETING AUTHORISATION NUMBER(S): EU/1/01/177/002, sulfur hexafluoride lipid-type A microspheres |
| Sponsor | GE Healthcare |
| Drug class | Ultrasound contrast agent |
| Modality | Small molecule |
| Therapeutic area | Imaging |
| Phase | Phase 3 |
Mechanism of action
It works by producing a large number of microbubbles that reflect sound waves, allowing for improved visualization of blood flow and tissue perfusion.
Approved indications
- Enhanced ultrasound imaging of the liver, spleen, and other organs
Common side effects
- Allergic reactions
Key clinical trials
- Interest of a Post-operative Ultrasound With Systematic Use of Ultrasonic Contrast in the Follow-up of Aortic Endoprosthesis: Prospective Study at the University Hospital of Nice (NA)
- Lumason® Infusion vs. Bolus Administrations (PHASE3)
- Pilot Study of Navigated Focused Ultrasound and Pembrolizumab in the Treatment of Recurrent WHO Grade 4 IDH-Wildtype Glioblastoma With Mismatch Repair Deficiency (PHASE1)
- Evaluation of Acute and Chronic Nephrotoxicity in Acute Lymphatic Leukemia Patients Using Ultrasound Localization Microscopy (NA)
- Placenta Accreta : Contrast-enhanced Ultrasound Analysis in High Risk Population (NA)
- 3D Contrast Enhanced Microvascular Ultrasound of Carotid Atherosclerosis for the Detection of Carotid Plaque Neo-Revascularisation. (NA)
- Pediatric Intravenous Contrast-Enhanced Ultrasound(CEUS) in China
- Kidney Disease and Ultrasound Imaging (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- SonoVue® CI brief — competitive landscape report
- SonoVue® updates RSS · CI watch RSS
- GE Healthcare portfolio CI